{"id":381141,"date":"2020-11-13T16:49:34","date_gmt":"2020-11-13T21:49:34","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=381141"},"modified":"2020-11-13T16:49:34","modified_gmt":"2020-11-13T21:49:34","slug":"beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/","title":{"rendered":"BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW YORK, Nov.  13, 2020  (GLOBE NEWSWIRE) &#8212; BeyondSpring Inc. (the \u201cCompany\u201d or \u201cBeyondSpring\u201d) (NASDAQ: BYSI), a global biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies to transform the lives of patients with unmet medical needs, today announced that management will provide a corporate overview at the Jefferies London Healthcare Conference on November 17<sup>th<\/sup>. Details are as follows:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"text-align: left;vertical-align: middle\">\n            <u><br \/>\n              <em><br \/>\n                <strong>Jefferies London Healthcare Conference (Presentation)<\/strong><br \/>\n              <\/em><br \/>\n            <\/u>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;text-align: right;vertical-align: middle\">\u00a0<\/td>\n<td style=\"max-width:80%;width:80%;min-width:80%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle\">Date:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle\">Tuesday, November 17<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle\">Time:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle\">2:55 pm Eastern Time<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle\">Webcast: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle\">\n            <a href=\"https:\/\/wsw.com\/webcast\/jeff141\/register.aspx?conf=jeff141&amp;page=bysi&amp;url=https:\/\/wsw.com\/webcast\/jeff141\/bysi\/1856775\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Click here to view webcast<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>The presentation will be webcast live and archived on BeyondSpring\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JIRcn57cD5y-Lc9EGAup1-XFXZEZG4GRS920Ki5fgpEc-bm7scS8IlHx7LIfSz7_lT6RNQOx0FOHbdTP0RIFc0DyUdaqRj2bzjHtRmocOb4dy_rbooQjPwbI_f7oOgI4\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>www.beyondspringpharma.com<\/strong><\/a>\u00a0under \u201cEvents &amp; Presentation&#8221; in the Investors section.<\/p>\n<p>\n        <strong>About BeyondSpring<\/strong><br \/>\n        <br \/> Headquartered in New York, BeyondSpring is a global, clinical-stage biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies to improve clinical outcomes for patients with high unmet medical needs. BeyondSpring\u2019s first-in-class lead immune asset, Plinabulin, is a potent antigen-presenting cell (APC) inducer. It is currently in two Phase 3 clinical trials for two severely unmet medical needs indications: one in combination with pegfilgrastim for the prevention of chemotherapy-induced neutropenia (CIN), the most frequent cause for a chemotherapy regimen dose\u2019s decrease, delay, downgrade or discontinuation, which can lead to suboptimal clinical outcomes. The Plinabulin and G-CSF combination regimen received breakthrough Therapy Designation from US FDA and China NMPA for the CIN indication. The other for non-small cell lung cancer (NSCLC) treatment in EGFR wild-type patients. As a \u201cpipeline drug,\u201d Plinabulin is in various I\/O combination studies to boost PD-1 \/ PD-L1 antibody anti-cancer effects. In addition to Plinabulin, BeyondSpring\u2019s extensive pipeline includes three pre-clinical immuno-oncology assets.\u00a0 Its subsidiary Seed Therapeutics has a proprietary drug discovery platform dubbed \u201cmolecular glue\u201d that uses the protein degradation pathway, for which Seed has a collaboration with Eli Lilly.\u00a0 <\/p>\n<p>\n        <strong>Investor Contact:<\/strong>\n      <\/p>\n<p>Ashley Robinson<br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4G_j38sr6H07m4wwNOtuct3iS6kNs6I_OwMDC3oYvMAFjQJo_e8xCBb01ig_3r6mEk8-iPhLJmtb73AsvJNbiyPnFyiVw911SIN7Y3wAom4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">arr@lifesciadvisors.com<\/a><br \/>617-430-7577<\/p>\n<p>Media Contact:<\/p>\n<p>Darren Opland, Ph.D.<br \/>LifeSci Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hYzONTyoY7_jE5DaoMh3Vq-xOGERrJOiJBPBs_CRKFLiNg7uL7U1stNYlLKJGwsoJGffZky6cvdpfH1oqk3v9KswpZDuC-mdMRN0SQxIp3s=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">darren@lifescicomms.com<\/a><br \/>646-627-8387<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjAzMSMzODI2OTkwIzUwMDA3NTY2MA==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/52317a50-0f4b-4616-aa96-8c0e5f8ce72e\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; BeyondSpring Inc. (the \u201cCompany\u201d or \u201cBeyondSpring\u201d) (NASDAQ: BYSI), a global biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies to transform the lives of patients with unmet medical needs, today announced that management will provide a corporate overview at the Jefferies London Healthcare Conference on November 17th. Details are as follows: Jefferies London Healthcare Conference (Presentation) \u00a0 \u00a0 Date:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tuesday, November 17 Time:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2:55 pm Eastern Time Webcast: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Click here to view webcast The presentation will be webcast live and archived on BeyondSpring\u2019s website at\u00a0www.beyondspringpharma.com\u00a0under \u201cEvents &amp; Presentation&#8221; in the Investors section. About BeyondSpring Headquartered in New York, BeyondSpring is a global, clinical-stage biopharmaceutical company focused on developing innovative immuno-oncology cancer &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-381141","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; BeyondSpring Inc. (the \u201cCompany\u201d or \u201cBeyondSpring\u201d) (NASDAQ: BYSI), a global biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies to transform the lives of patients with unmet medical needs, today announced that management will provide a corporate overview at the Jefferies London Healthcare Conference on November 17th. Details are as follows: Jefferies London Healthcare Conference (Presentation) \u00a0 \u00a0 Date:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tuesday, November 17 Time:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2:55 pm Eastern Time Webcast: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Click here to view webcast The presentation will be webcast live and archived on BeyondSpring\u2019s website at\u00a0www.beyondspringpharma.com\u00a0under \u201cEvents &amp; Presentation&#8221; in the Investors section. About BeyondSpring Headquartered in New York, BeyondSpring is a global, clinical-stage biopharmaceutical company focused on developing innovative immuno-oncology cancer &hellip; Continue reading &quot;BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-13T21:49:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjAzMSMzODI2OTkwIzUwMDA3NTY2MA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference\",\"datePublished\":\"2020-11-13T21:49:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\\\/\"},\"wordCount\":319,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NjAzMSMzODI2OTkwIzUwMDA3NTY2MA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\\\/\",\"name\":\"BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NjAzMSMzODI2OTkwIzUwMDA3NTY2MA==\",\"datePublished\":\"2020-11-13T21:49:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NjAzMSMzODI2OTkwIzUwMDA3NTY2MA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NjAzMSMzODI2OTkwIzUwMDA3NTY2MA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference - Market Newsdesk","og_description":"NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; BeyondSpring Inc. (the \u201cCompany\u201d or \u201cBeyondSpring\u201d) (NASDAQ: BYSI), a global biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies to transform the lives of patients with unmet medical needs, today announced that management will provide a corporate overview at the Jefferies London Healthcare Conference on November 17th. Details are as follows: Jefferies London Healthcare Conference (Presentation) \u00a0 \u00a0 Date:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tuesday, November 17 Time:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2:55 pm Eastern Time Webcast: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Click here to view webcast The presentation will be webcast live and archived on BeyondSpring\u2019s website at\u00a0www.beyondspringpharma.com\u00a0under \u201cEvents &amp; Presentation&#8221; in the Investors section. About BeyondSpring Headquartered in New York, BeyondSpring is a global, clinical-stage biopharmaceutical company focused on developing innovative immuno-oncology cancer &hellip; Continue reading \"BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-13T21:49:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjAzMSMzODI2OTkwIzUwMDA3NTY2MA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference","datePublished":"2020-11-13T21:49:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/"},"wordCount":319,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjAzMSMzODI2OTkwIzUwMDA3NTY2MA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/","name":"BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjAzMSMzODI2OTkwIzUwMDA3NTY2MA==","datePublished":"2020-11-13T21:49:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjAzMSMzODI2OTkwIzUwMDA3NTY2MA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjAzMSMzODI2OTkwIzUwMDA3NTY2MA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-to-present-corporate-overview-at-jefferies-london-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=381141"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381141\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=381141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=381141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=381141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}